EyeBio | LinkedIn (original) (raw)

``

Biotechnology Research

Developing a new generation of therapies to protect, restore, and improve vision

About us

EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.

Industry

Biotechnology Research

Company size

11-50 employees

Headquarters

London

Type

Privately Held

Founded

2021

Specialties

ophthalmology, biopharmaceuticals, and biotechnology

Locations

Employees at EyeBio

Updates

Join now to see what you are missing

Join now

Similar pages

Browse jobs

Funding